Heidi Beadnall

1.0k total citations
26 papers, 643 citations indexed

About

Heidi Beadnall is a scholar working on Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Heidi Beadnall has authored 26 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 5 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Molecular Biology. Recurrent topics in Heidi Beadnall's work include Multiple Sclerosis Research Studies (18 papers), Extracellular vesicles in disease (3 papers) and Peripheral Neuropathies and Disorders (3 papers). Heidi Beadnall is often cited by papers focused on Multiple Sclerosis Research Studies (18 papers), Extracellular vesicles in disease (3 papers) and Peripheral Neuropathies and Disorders (3 papers). Heidi Beadnall collaborates with scholars based in Australia, United States and United Kingdom. Heidi Beadnall's co-authors include Michael Barnett, Michael E. Buckland, Fatemeh Vafaee, Catherine M. Suter, Saeideh Ebrahimkhani, Paul Young, Chenyu Wang, Simon Hawke, Emma Devenney and Suzy S. J. Hur and has published in prestigious journals such as Neurology, Scientific Reports and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Heidi Beadnall

21 papers receiving 636 citations

Peers

Heidi Beadnall
Ran Xu Germany
Alexander Musallam United States
G. Cole United Kingdom
Mark Marriott Australia
Heidi Beadnall
Citations per year, relative to Heidi Beadnall Heidi Beadnall (= 1×) peers Maria Antonietta Mazzola

Countries citing papers authored by Heidi Beadnall

Since Specialization
Citations

This map shows the geographic impact of Heidi Beadnall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi Beadnall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi Beadnall more than expected).

Fields of papers citing papers by Heidi Beadnall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidi Beadnall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi Beadnall. The network helps show where Heidi Beadnall may publish in the future.

Co-authorship network of co-authors of Heidi Beadnall

This figure shows the co-authorship network connecting the top 25 collaborators of Heidi Beadnall. A scholar is included among the top collaborators of Heidi Beadnall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi Beadnall. Heidi Beadnall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beadnall, Heidi, et al.. (2025). Ravulizumab-related meningococcal sepsis post rituximab. Practical Neurology. 25(6). 553–557.
2.
Beadnall, Heidi, et al.. (2025). Impact of pregnancy on the maternal brain in health and multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 96(6). 593–605.
4.
Liu, Dongnan, Mariano Cabezas, Dongang Wang, et al.. (2022). DAMS-Net: A Domain Adaptive Lesion Segmentation Framework in Patients with Multiple Sclerosis from Multiple Imaging Centers (P18-4.001). Neurology. 98(18_supplement). 1 indexed citations
5.
Penninkilampi, Ross, Heidi Beadnall, Michael Fulham, et al.. (2022). 2445 A rare case of Erdheim-Chester Disease associated with anti-GABA-B antibodies. Abstracts. A63.2–A63.
6.
Sharpe, Louise, et al.. (2022). A randomized controlled trial of a web-based mindfulness programme for people with MS with and without a history of recurrent depression. Multiple Sclerosis Journal. 28(9). 1392–1401. 15 indexed citations
7.
Wang, Chenyu, Joshua Barton, Linda Ly, et al.. (2021). Multiple sclerosis: structural and functional integrity of the visual system following alemtuzumab therapy. Journal of Neurology Neurosurgery & Psychiatry. 92(12). 1319–1324. 9 indexed citations
8.
Trewin, Benjamin, Stephen Adelstein, Judith Spies, et al.. (2020). Precision therapy for neuromyelitis optica spectrum disorder: A retrospective analysis of the use of class-switched memory B-cells for individualised rituximab dosing schedules. Multiple Sclerosis and Related Disorders. 43. 102175–102175. 9 indexed citations
9.
Sharpe, Louise, et al.. (2020). Development of a Web-Based Mindfulness Program for People With Multiple Sclerosis: Qualitative Co-Design Study. Journal of Medical Internet Research. 23(3). e19309–e19309. 9 indexed citations
10.
Rinaldi, Simon, Alexander J. Davies, Janev Fehmi, et al.. (2020). Overlapping central and peripheral nervous system syndromes in MOG antibody–associated disorders. Neurology Neuroimmunology & Neuroinflammation. 8(1). 61 indexed citations
11.
Silsby, Matthew, Judith Spies, Joshua Barton, et al.. (2019). Investigation of tumefactive demyelination is associated with higher economic burden and more adverse events compared with conventional multiple sclerosis. Multiple Sclerosis and Related Disorders. 35. 104–107. 7 indexed citations
12.
Ebrahimkhani, Saeideh, Heidi Beadnall, Chenyu Wang, et al.. (2019). Serum Exosome MicroRNAs Predict Multiple Sclerosis Disease Activity after Fingolimod Treatment. Molecular Neurobiology. 57(2). 1245–1258. 40 indexed citations
13.
Sharpe, Louise, et al.. (2019). The evaluation of an online mindfulness program for people with multiple sclerosis: study protocol. BMC Neurology. 19(1). 129–129. 11 indexed citations
14.
Ebrahimkhani, Saeideh, Fatemeh Vafaee, Susannah Hallal, et al.. (2018). Deep sequencing of circulating exosomal microRNA allows non-invasive glioblastoma diagnosis. npj Precision Oncology. 2(1). 28–28. 118 indexed citations
15.
Ebrahimkhani, Saeideh, Fatemeh Vafaee, Paul Young, et al.. (2017). Exosomal microRNA signatures in multiple sclerosis reflect disease status. Scientific Reports. 7(1). 14293–14293. 222 indexed citations
16.
Beadnall, Heidi, et al.. (2017). The evolution of “No Evidence of Disease Activity” in multiple sclerosis. Multiple Sclerosis and Related Disorders. 20. 231–238. 41 indexed citations
17.
Beadnall, Heidi, et al.. (2017). The prognostic utility of no evidence of disease activity (neda). Journal of Neurology Neurosurgery & Psychiatry. 88(5). e1.8–e1.
18.
Oliver, Ruth, Linda Ly, Chenyu Wang, et al.. (2017). Complete partial volume solution for ASL brain perfusion data applied to relapse remitting multiple sclerosis patients. 6804–6806. 1 indexed citations
19.
Wang, Chenyu, Heidi Beadnall, Sean N. Hatton, et al.. (2016). Automated brain volumetrics in multiple sclerosis: a step closer to clinical application. Journal of Neurology Neurosurgery & Psychiatry. 87(7). 754–757. 46 indexed citations
20.
Beadnall, Heidi, et al.. (2015). Tablet‐based screening improves continence management in multiple sclerosis. Annals of Clinical and Translational Neurology. 2(6). 679–687. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026